Citations (114)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Yoshie Sakamaki, John Ozdemir, Zachary Heidrick, Olivia Watson, Hamid R. Shahsavari, Masood Fereidoonnezhad, Ahmad R. Khosropour & M. Hassan Beyzavi. (2018) Metal–Organic Frameworks and Covalent Organic Frameworks as Platforms for Photodynamic Therapy. Comments on Inorganic Chemistry 38:6, pages 238-293.
Read now
Read now
Alexander M. Scherbakov, Alexander M. Borunov, Galina I. Buravchenko, Olga E. Andreeva, Igor A. Kudryavtsev, Lyubov G. Dezhenkova & Andrey E. Shchekotikhin. (2018) Novel Quinoxaline-2-Carbonitrile-1,4-Dioxide Derivatives Suppress HIF1α Activity and Circumvent MDR in Cancer Cells. Cancer Investigation 36:3, pages 199-209.
Read now
Read now
Meghna Talekar, Srinivas Reddy Boreddy, Amit Singh & Mansoor Amiji. (2014) Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery. Expert Opinion on Biological Therapy 14:8, pages 1145-1159.
Read now
Read now
Alfonso Dueñas-Gonzalez, Lucely Cetina, Jaime Coronel, Claudia Cano & Rigoberto Dolores. (2014) New pharmacotherapy options for cervical cancer. Expert Opinion on Pharmacotherapy 15:1, pages 51-60.
Read now
Read now
Prafull Ghatage & Hassan Sabagh. (2012) Is there a role for tirapazamine in the treatment of cervical cancer?. Expert Opinion on Drug Metabolism & Toxicology 8:12, pages 1589-1597.
Read now
Read now
Alfonso Dueñas-Gonzalez, Lucely Cetina, Jaime Coronel & Diana Cervantes-Madrid. (2012) Emerging drugs for cervical cancer. Expert Opinion on Emerging Drugs 17:2, pages 203-218.
Read now
Read now
Pierre Bischoff, Anais Altmeyer & Francis Dumont. (2009) Radiosensitising agents for the radiotherapy of cancer: advances in traditional and hypoxia targeted radiosensitisers. Expert Opinion on Therapeutic Patents 19:5, pages 643-662.
Read now
Read now
Articles from other publishers (107)
Ying Wang, Gareth R. Williams, Yilu Zheng, Honghua Guo, Shiyan Chen, Rong Ren, Tong Wang, Jindong Xia & Li-Min Zhu. (2023) Polydopamine-cloaked Fe-based metal organic frameworks enable synergistic multidimensional treatment of osteosarcoma. Journal of Colloid and Interface Science 651, pages 76-92.
Crossref
Crossref
Benzion Amoyav, Allan I. Bloom, Yoel Goldstein, Rafael Miller, Mariana Sharam, Arnon Fluksman & Ofra Benny. (2023) Drug‐Eluting Porous Embolic Microspheres for Trans‐Arterial Delivery of Dual Synergistic Anticancer Therapy for the Treatment of Liver Cancer. Advanced Healthcare Materials 12:30.
Crossref
Crossref
Wenbin Hu, Sanying Wang, Chenyi Jiang, Minbin Zheng, Zhi Bai, Devyani Srivastava, Abhinav Kumar & Jianqiang Liu. (2023) Recent advances in sonodynamic therapy by MOFs-based platforms for biomedical applications. Dyes and Pigments 219, pages 111596.
Crossref
Crossref
Jingtao Zheng, Yanyan Pan, Yubin Chen, Junyan Li & Weishuo Li. (2023) Hypoxic tumor therapy based on free radicals. Materials Chemistry Frontiers 7:17, pages 3576-3594.
Crossref
Crossref
Kin Fai Tan, Lionel Lian Aun In & Palanirajan Vijayaraj Kumar. (2023) Surface Functionalization of Gold Nanoparticles for Targeting the Tumor Microenvironment to Improve Antitumor Efficiency. ACS Applied Bio Materials 6:8, pages 2944-2981.
Crossref
Crossref
Naemah Haji, Masoma Faizi, Panayiotis A. Koutentis, Michael P. Carty & Fawaz Aldabbagh. (2023) Heterocyclic Iminoquinones and Quinones from the National Cancer Institute (NCI, USA) COMPARE Analysis. Molecules 28:13, pages 5202.
Crossref
Crossref
Jianhang Huang, Peng YuMochou Liao, Xiaoli Dong, Jie Xu, Jiang Ming, Duan BinYonggang Wang, Fan Zhang & Yongyao Xia. (2023) A self-charging salt water battery for antitumor therapy. Science Advances 9:13.
Crossref
Crossref
Lu Yang, Zhao Wang, HaiJiang Gong, Shili Gai & RuiFang Shen. (2023) Tirapazamine-loaded UiO-66/Cu for ultrasound-mediated promotion of chemodynamic therapy cascade hypoxia-activated anticancer therapy. Journal of Colloid and Interface Science 634, pages 495-508.
Crossref
Crossref
Danling Cheng, Jiacheng He, Chuanhong Zhang, Yijing Zhang, Ningyue Yu, Rong Cai, Xiuhui Wang & Jingchao Li. (2022) Inhibitor-Decorated Nanoscale Semiconducting Polymer Prodrugs for Photodynamically Amplified Chemotherapy and Metastasis Inhibition. ACS Applied Nano Materials 6:1, pages 421-430.
Crossref
Crossref
Sasmita Das, Mohammed Adil Shareef & Bhaskar C. Das. (2023) Design and Synthesis of New Boron-Based Benzo[c][1,2,5]oxadiazoles and Benzo[c][1,2,5]thiadiazoles as Potential Hypoxia Inhibitors. Inorganics 11:1, pages 34.
Crossref
Crossref
Xiang Liu, Shaowen Du, Shengdong Wang & Kaishan Ye. (2022) Ferroptosis in osteosarcoma: A promising future. Frontiers in Oncology 12.
Crossref
Crossref
Pradipta Ranjan Rauta, Yuri Mackeyev, Keith Sanders, Joseph B.K. KimValeria V. Gonzalez, Yasmin Zahra, Muhammad A. Shohayeb, Belal Abousaida, Geraldine V. Vijay, Okan TezcanPaul DerryAnton V. LiopoEugene R. ZubarevRickey Carter, Pankaj SinghSunil Krishnan. (2022) Pancreatic tumor microenvironmental acidosis and hypoxia transform gold nanorods into cell-penetrant particles for potent radiosensitization. Science Advances 8:45.
Crossref
Crossref
Jianyang Zhao, Yi-Yang Peng, Diana Diaz-Dussan, Jacinta White, Wei Duan, Lingxue Kong, Ravin Narain & Xiaojuan Hao. (2021) Zwitterionic Block Copolymer Prodrug Micelles for pH Responsive Drug Delivery and Hypoxia-Specific Chemotherapy. Molecular Pharmaceutics 19:6, pages 1766-1777.
Crossref
Crossref
Giimel Ajnai, Chun-Chia Cheng, Tzu-Chun Kan, Jeng-Wei Lu, Sri Rahayu, Amy Chiu & Jungshan Chang. (2022) Improving Tirapazamine (TPZ) to Target and Eradicate Hypoxia Tumors by Gold Nanoparticle Carriers. Pharmaceutics 14:4, pages 847.
Crossref
Crossref
Zhu Yu, Wenlong Cao, Chuangye Han, Zhen Wang, Yue Qiu, Jiancheng Wang, Mengda Wei, Junfu Wang, Siwen Zhang, Senfeng Liu, Shutian Mo & Junqiang Chen. (2022) Biomimetic Metal-Organic Framework Nanoparticles for Synergistic Combining of SDT-Chemotherapy Induce Pyroptosis in Gastric Cancer. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Yuanyuan Li, Aiyang Tong, Peiyuan Niu, Wenjing Guo, Yangye Jin, Yi Hu, Pei Tao & Wenjun Miao. (2022) Light-Decomposable Polymeric Micelles with Hypoxia-Enhanced Phototherapeutic Efficacy for Combating Metastatic Breast Cancer. Pharmaceutics 14:2, pages 253.
Crossref
Crossref
Defne Yilmaz, Mert Tuzer & Mehmet Burcin Unlu. (2022) Assessing the therapeutic response of tumors to hypoxia-targeted prodrugs with an <i>in silico</i> approach. Mathematical Biosciences and Engineering 19:11, pages 10941-10962.
Crossref
Crossref
Jeffrey R. Brender, Yu SaidaNallathamby DevasahayamMurali C. KrishnaShun Kishimoto. (2022) Hypoxia Imaging As a Guide for Hypoxia-Modulated and Hypoxia-Activated Therapy. Antioxidants & Redox Signaling 36:1-3, pages 144-159.
Crossref
Crossref
David A. Close & Paul A. Johnston. (2022) Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines. SLAS Discovery 27:1, pages 39-54.
Crossref
Crossref
Carlos A. C. Fraga, Daniela P. S. P. Souza, Hellen C. S. Lima, Lucyana C. Farias & André Luiz Sena Guimarães. 2022.
Yi-Te Chou, Chih-Yu Lin, Jyun-Wei Wen, Ling-Chun Hung, Ying-Feng Chang, Chia-Min Yang, Li-chen Wu & Ja-an Annie Ho. (2021) Targeting triple‐negative breast cancer with an aptamer‐functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies. Journal of Nanobiotechnology 19:1.
Crossref
Crossref
Xia Hong, Xiaomei Xu, Zhicheng Liu, Shupeng Liu, Jie Yu, Mingyuan Wu, Yuwei Ma & Qi Shuai. (2021) Hyaluronan-fullerene/AIEgen nanogel as CD44-targeted delivery of tirapazamine for synergistic photodynamic-hypoxia activated therapy. Nanotechnology 32:46, pages 465701.
Crossref
Crossref
Alain C. Jung, Fabien Moinard-Butot, Chloé Thibaudeau, Gilles Gasser & Christian Gaiddon. (2021) Antitumor Immune Response Triggered by Metal-Based Photosensitizers for Photodynamic Therapy: Where Are We?. Pharmaceutics 13:11, pages 1788.
Crossref
Crossref
Jiazheng Zhao, Yi Zhao, Xiaowei Ma, Benzheng Zhang & Helin Feng. (2021) Targeting ferroptosis in osteosarcoma. Journal of Bone Oncology 30, pages 100380.
Crossref
Crossref
Vera L. Silva, Amalia Ruiz, Ahlam Ali, Sara Pereira, Jani Seitsonen, Janne Ruokolainen, Fiona Furlong, Jonathan Coulter & Wafa' T. Al-Jamal. (2021) Hypoxia-targeted cupric-tirapazamine liposomes potentiate radiotherapy in prostate cancer spheroids. International Journal of Pharmaceutics 607, pages 121018.
Crossref
Crossref
Elena Refet-Mollof, Ouafa Najyb, Rodin Chermat, Audrey Glory, Julie Lafontaine, Philip Wong & Thomas Gervais. (2021) Hypoxic Jumbo Spheroids On-A-Chip (HOnAChip): Insights into Treatment Efficacy. Cancers 13:16, pages 4046.
Crossref
Crossref
Julien Ancel, Jeanne-Marie Perotin, Maxime Dewolf, Claire Launois, Pauline Mulette, Béatrice Nawrocki-Raby, Véronique Dalstein, Christine Gilles, Gaëtan Deslée, Myriam Polette & Valérian Dormoy. (2021) Hypoxia in Lung Cancer Management: A Translational Approach. Cancers 13:14, pages 3421.
Crossref
Crossref
Manal Mehibel, Yu Xu, Caiyun G. Li, Eui Jung Moon, Kaushik N. Thakkar, Anh N. Diep, Ryan K. Kim, Joshua D. Bloomstein, Yiren Xiao, Julien Bacal, Joshua C. Saldivar, Quynh-Thu Le, Karlene A. Cimprich, Erinn B. Rankin & Amato J. Giaccia. (2021) Eliminating hypoxic tumor cells improves response to PARP inhibitors in homologous recombination–deficient cancer models. Journal of Clinical Investigation 131:11.
Crossref
Crossref
Yao Yang, Weiwei Zeng, Ping Huang, Xiaowei Zeng & Lin Mei. (2020) Smart materials for drug delivery and cancer therapy. VIEW 2:2.
Crossref
Crossref
Donghyun Lee, Seok-young Jang, Soonmin Kwon, Yeeun Lee, Eunyoung Park & Heebeom Koo. (2021) Optimized Combination of Photodynamic Therapy and Chemotherapy Using Gelatin Nanoparticles Containing Tirapazamine and Pheophorbide a. ACS Applied Materials & Interfaces 13:9, pages 10812-10821.
Crossref
Crossref
Victoria L. Codony & Mahvash Tavassoli. (2021) Hypoxia-induced therapy resistance: Available hypoxia-targeting strategies and current advances in head and neck cancer. Translational Oncology 14:3, pages 101017.
Crossref
Crossref
Yinghua Zhang, Huifang Liu, Xinyue Dai, Hang Li, Xiaohan Zhou, Shizhu Chen, Jinchao Zhang, Xing-Jie Liang & Zhenhua Li. (2020) Cyanobacteria-based near-infrared light-excited self-supplying oxygen system for enhanced photodynamic therapy of hypoxic tumors. Nano Research 14:3, pages 667-673.
Crossref
Crossref
Miriam de J. Velásquez-Hernández, Mercedes Linares-Moreau, Efwita Astria, Francesco Carraro, Mram Z. Alyami, Niveen M. Khashab, Christopher J. Sumby, Christian J. Doonan & Paolo Falcaro. (2021) Towards applications of bioentities@MOFs in biomedicine. Coordination Chemistry Reviews 429, pages 213651.
Crossref
Crossref
Anna Szymanowska, Agnieszka Gornowicz, Anna Bielawska & Krzysztof Bielawski. (2021) [1,2,4]triazyny – potencjalne leki w chemioterapii nowotworów. Postępy Higieny i Medycyny Doświadczalnej 75:1, pages 64-84.
Crossref
Crossref
Xiao-Qiang Wang, Wenjing Wang, Mengyun Peng & Xian-Zheng Zhang. (2021) Free radicals for cancer theranostics. Biomaterials 266, pages 120474.
Crossref
Crossref
Jianyang Zhao, Diana Diaz-Dussan, Zhiqiang Jiang, Yi-Yang Peng, Jacinta White, Wei Duan, Ravin Narain, Xiaojuan Hao & Lingxue Kong. (2020) Facile Preparation of Macromolecular Prodrugs for Hypoxia-Specific Chemotherapy. ACS Macro Letters 9:11, pages 1687-1692.
Crossref
Crossref
Morten Busk, Jens Overgaard & Michael R. Horsman. (2020) Imaging of Tumor Hypoxia for Radiotherapy: Current Status and Future Directions. Seminars in Nuclear Medicine 50:6, pages 562-583.
Crossref
Crossref
Tarawanti Verma, Manish Sinha & Nitin Bansal. (2020) Synthesis of Novel 1,2-Dihydro-1,2,4-Triazin-6(5H)-one Derivatives as Anticancer Agents. Current Bioactive Compounds 16:7, pages 1116-1131.
Crossref
Crossref
Marcos V. Palmeira-Mello, Ana B. Caballero, Juliana Martins Ribeiro, Elaine Maria de Souza-Fagundes, Patrick Gamez & Mauricio Lanznaster. (2020) Evaluation of cobalt(III) complexes as potential hypoxia-responsive carriers of esculetin. Journal of Inorganic Biochemistry 211, pages 111211.
Crossref
Crossref
Philippe Lienard & Steven Elenbaas. (2020) Development and Validation of a Kilogram-Scale Synthesis of Tirapazamine. ACS Omega 5:27, pages 16556-16561.
Crossref
Crossref
Evelina Polmickaitė-Smirnova, Jonas Šarlauskas, Kastis Krikštopaitis, Živilė Lukšienė, Zita Staniulytė & Žilvinas Anusevičius. (2020) Preliminary Investigation of the Antibacterial Activity of Antitumor Drug 3-Amino-1,2,4-Benzotriazine-1,4-Dioxide (Tirapazamine) and its Derivatives. Applied Sciences 10:12, pages 4062.
Crossref
Crossref
Ana Katrina Mapanao & Valerio Voliani. (2020) Three-dimensional tumor models: Promoting breakthroughs in nanotheranostics translational research. Applied Materials Today 19, pages 100552.
Crossref
Crossref
Vera L. Silva, Abdessamad Kaassis, Ashkan Dehsorkhi, Cédrik-Roland Koffi, Maja Severic, Moustafa Abdelhamid, Duuamene Nyimanu, Christopher J. Morris & Wafa’ T. Al-Jamal. (2020)
Enhanced selectivity, cellular uptake, and
in vitro
activity of an intrinsically fluorescent copper–tirapazamine nanocomplex for hypoxia targeted therapy in prostate cancer
. Biomaterials Science 8:9, pages 2420-2433.
Crossref
Crossref
Shuqi Guo, Rongfeng Liu, Wei Wang, Hongbo Hu, Zhiyong Li & Xuehong Zhang. (2020)
Designing an Artificial Pathway for the Biosynthesis of a Novel Phenazine
N
-Oxide in
Pseudomonas chlororaphis
HT66
. ACS Synthetic Biology 9:4, pages 883-892.
Crossref
Crossref
Agnieszka Korga, Magdalena Iwan, Dariusz Matosiuk, Marzena Rzadkowska, Elzbieta Szacon, Ewelina Humeniuk, Marcin Sysa, Marta Ostrowska & Jaroslaw Dudka. (2020) New tirapazamine derivatives protect cardiomyocytes from doxorubicin toxicity. Current Issues in Pharmacy and Medical Sciences 33:1, pages 1-5.
Crossref
Crossref
Ryan D. Kruschel, Alyah Buzid, Udaya B. Rao Khandavilli, Simon E. Lawrence, Jeremy D. Glennon & Florence O. McCarthy. (2020)
Isoquinolinequinone
N
-oxides as anticancer agents effective against drug resistant cell lines
. Organic & Biomolecular Chemistry 18:3, pages 557-568.
Crossref
Crossref
Mingkang Zhang, Jing-Jie Ye, Yu Xia, Zi-Yang Wang, Chu-Xin Li, Xiao-Shuang Wang, Wuyang Yu, Wen Song, Jun Feng & Xian-Zheng Zhang. (2019) Platelet-Mimicking Biotaxis Targeting Vasculature-Disrupted Tumors for Cascade Amplification of Hypoxia-Sensitive Therapy. ACS Nano 13:12, pages 14230-14240.
Crossref
Crossref
Anil Parsram Bidkar, Pallab Sanpui & Siddhartha Sankar Ghosh. (2019)
Red Blood Cell-Membrane-Coated Poly(Lactic-
co
-glycolic Acid) Nanoparticles for Enhanced Chemo- and Hypoxia-Activated Therapy
. ACS Applied Bio Materials 2:9, pages 4077-4086.
Crossref
Crossref
Marwa H. El-Wakil, Amira F. El-Yazbi, Hayam M.A. Ashour, Mounir A. Khalil, Khadiga A. Ismail & Ibrahim M. Labouta. (2019) Discovery of a novel DNA binding agent via design and synthesis of new thiazole hybrids and fused 1,2,4-triazines as potential antitumor agents: Computational, spectrometric and in silico studies. Bioorganic Chemistry 90, pages 103089.
Crossref
Crossref
Almir S. Gazizov, Yulia M. Sadykova, Elmira M. Gibadullina, Alexander R. Burilov, Lyudmila K. Kibardina, Irina R. Knyazeva, Alexey V. Trifonov & Oleg G. Sinyashin. (2019) Elements of the Fifth Group of the Periodic System of D.I. Mendeleev – the Elements of Life. Vestnik RFFI:2, pages 26-45.
Crossref
Crossref
Wenguang Wang, Yuhao Cheng, Peng Yu, Haoran Wang, Yue Zhang, Haiheng Xu, Qingsong Ye, Ahu Yuan, Yiqiao Hu & Jinhui Wu. (2019) Perfluorocarbon regulates the intratumoural environment to enhance hypoxia-based agent efficacy. Nature Communications 10:1.
Crossref
Crossref
Linda Spiegelberg, Ruud Houben, Raymon Niemans, Dirk de Ruysscher, Ala Yaromina, Jan Theys, Christopher P. Guise, Jeffrey B. Smaill, Adam V. Patterson, Philippe Lambin & Ludwig J. Dubois. (2019) Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials. Clinical and Translational Radiation Oncology 15, pages 62-69.
Crossref
Crossref
Josh W. DiGiacomo & Daniele M. Gilkes. 2019. Hypoxia and Cancer Metastasis. Hypoxia and Cancer Metastasis
141
157
.
Hang Zhou, Juanhong Gao, Zhaohang Chen, Shan Duan, Chao Li & Renzhong Qiao. (2018) Double-strand cleavage of DNA by a polyamide-phenazine-di-N-oxide conjugate. Bioorganic & Medicinal Chemistry Letters 28:3, pages 284-288.
Crossref
Crossref
Jianghong Man, Xingjiang Yu, Haidong Huang, Wenchao Zhou, Chaomei Xiang, Haohao Huang, Lucio Miele, Zhenggang Liu, Gurkan Bebek, Shideng Bao & Jennifer S. Yu. (2018) Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells. Cell Stem Cell 22:1, pages 104-118.e6.
Crossref
Crossref
Lam-Huyen Nguyen-Thi, Sinh Truong Nguyen, Thao Phuong Tran, Chinh-Nhan Phan-Lu, Phuc Van Pham & Trung The Van. 2020. Cancer Biology and Advances in Treatment. Cancer Biology and Advances in Treatment
13
25
.
Yuta Ando, Hoang P. Ta, Daniel P. Yen, Sang-Sin Lee, Sneha Raola & Keyue Shen. (2017) A Microdevice Platform Recapitulating Hypoxic Tumor Microenvironments. Scientific Reports 7:1.
Crossref
Crossref
A. Paden King, Hendryck A. Gellineau, Jung-Eun Ahn, Samantha N. MacMillan & Justin J. Wilson. (2017) Bis(thiosemicarbazone) Complexes of Cobalt(III). Synthesis, Characterization, and Anticancer Potential. Inorganic Chemistry 56:11, pages 6609-6623.
Crossref
Crossref
Aida M. Basri, Rianne M. Lord, Simon J. Allison, Andrea Rodríguez‐Bárzano, Stephanie J. Lucas, Felix D. Janeway, Helena J. Shepherd, Christopher M. Pask, Roger M. Phillips & Patrick C. McGowan. (2017)
Bis‐picolinamide Ruthenium(III) Dihalide Complexes: Dichloride‐to‐Diiodide Exchange Generates Single
trans
Isomers with High Potency and Cancer Cell Selectivity
. Chemistry – A European Journal 23:26, pages 6341-6356.
Crossref
Crossref
Vera L. Silva & Wafa' T. Al-Jamal. (2017) Exploiting the cancer niche: Tumor-associated macrophages and hypoxia as promising synergistic targets for nano-based therapy. Journal of Controlled Release 253, pages 82-96.
Crossref
Crossref
Yazhe Wang, Ying Xie, Jing Li, Zheng-Hong Peng, Yuri Sheinin, Jianping Zhou & David Oupický. (2017) Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy. ACS Nano 11:2, pages 2227-2238.
Crossref
Crossref
Simon J.A. van Kuijk, Nanda Kumar Parvathaneni, Raymon Niemans, Marike W. van Gisbergen, Fabrizio Carta, Daniela Vullo, Silvia Pastorekova, Ala Yaromina, Claudiu T. Supuran, Ludwig J. Dubois, Jean-Yves Winum & Philippe Lambin. (2017) New approach of delivering cytotoxic drugs towards CAIX expressing cells: A concept of dual-target drugs. European Journal of Medicinal Chemistry 127, pages 691-702.
Crossref
Crossref
M.P. Hay, K.O. Hicks & W.R. Wilson. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
58
94
.
Slawomir Mandziuk, Wlodzimierz Matysiak, Agnieszka Korga, Franciszek Burdan, Iwona Pasnik, Marcin Hejna, Agnieszka Korobowicz-Markiewicz, Luiza Grzycka-Kowalczyk, Michal Kowalczyk, Ewa Poleszak, Barbara Jodlowska-Jedrych & Jaroslaw Dudka. (2016) Tirapazamine has no Effect on Hepatotoxicity of Cisplatin and 5-fluorouracil but Interacts with Doxorubicin Leading to Side Changes in Redox Equilibrium. Basic & Clinical Pharmacology & Toxicology 119:3, pages 330-340.
Crossref
Crossref
Bishnubrata Patra, Chien-Chung Peng, Wei-Hao Liao, Chau-Hwang Lee & Yi-Chung Tung. (2016) Drug testing and flow cytometry analysis on a large number of uniform sized tumor spheroids using a microfluidic device. Scientific Reports 6:1.
Crossref
Crossref
Andrew Vaughan & Shyam S. D. Rao. 2016. Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy. Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy
11
19
.
Hua Fang & Yves A. DeClerck. 2015. Targeted Therapy in Translational Cancer Research. Targeted Therapy in Translational Cancer Research
47
63
.
Ludwig J. Dubois, Raymon Niemans, Simon J.A. van Kuijk, Kranthi M. Panth, Nanda-Kumar Parvathaneni, Sarah G.J.A. Peeters, Catharina M.L. Zegers, Nicolle H. Rekers, Marike W. van Gisbergen, Rianne Biemans, Natasja G. Lieuwes, Linda Spiegelberg, Ala Yaromina, Jean-Yves Winum, Marc Vooijs & Philippe Lambin. (2015) New ways to image and target tumour hypoxia and its molecular responses. Radiotherapy and Oncology 116:3, pages 352-357.
Crossref
Crossref
Geoff S. Higgins, Sean M. O’Cathail, Ruth J. Muschel & W. Gillies McKenna. (2015) Drug radiotherapy combinations: Review of previous failures and reasons for future optimism. Cancer Treatment Reviews 41:2, pages 105-113.
Crossref
Crossref
Juliana Benito, Marina Konopleva & William R. Wilson. 2015. Targeted Therapy of Acute Myeloid Leukemia. Targeted Therapy of Acute Myeloid Leukemia
657
679
.
Kate M. Bailey, Heather H. Cornnell, Arig Ibrahim-Hashim, Jonathan W. Wojtkowiak, Charles P. Hart, Xiaomeng Zhang, Rafael Leos, Gary V. Martinez, Amanda F. Baker & Robert J. Gillies. (2014) Evaluation of the “Steal” Phenomenon on the Efficacy of Hypoxia Activated Prodrug TH-302 in Pancreatic Cancer. PLoS ONE 9:12, pages e113586.
Crossref
Crossref
Ron R Allison. (2014) Radiobiological modifiers in clinical radiation oncology: current reality and future potential. Future Oncology 10:15, pages 2359-2379.
Crossref
Crossref
J.L. Bryant, S.L. Meredith, K.J. Williams & A. White. (2014) Targeting hypoxia in the treatment of small cell lung cancer. Lung Cancer 86:2, pages 126-132.
Crossref
Crossref
Yongchuan Gu, Jagdish K. Jaiswal, Jingli Wang, Kevin O. Hicks, Michael P. Hay & William R. Wilson. (2014) Photodegradation of the Benzotriazine 1,4-Di-N-Oxide Hypoxia-Activated Prodrug SN30000 in Aqueous Solution. Journal of Pharmaceutical Sciences 103:11, pages 3464-3472.
Crossref
Crossref
Jingli Wang, Chris P. Guise, Gabi U. Dachs, Yen Phung, Annie (Huai-Ling) Hsu, Neil K. Lambie, Adam V. Patterson & William R. Wilson. (2014) Identification of one-electron reductases that activate both the hypoxia prodrug SN30000 and diagnostic probe EF5. Biochemical Pharmacology 91:4, pages 436-446.
Crossref
Crossref
Sang-Hak Lee, Jae Nam, Jong-Kook Park, Joo-Ho Lee, Do Min & Hyo-Jeong Kuh. (2014) Differential protein expression and novel biomarkers related to 5-FU resistance in a 3D colorectal adenocarcinoma model. Oncology Reports.
Crossref
Crossref
Jasdeep K. Saggar & Ian F. Tannock. (2014) Activity of the hypoxia-activated pro-drug TH-302 in hypoxic and perivascular regions of solid tumors and its potential to enhance therapeutic effects of chemotherapy. International Journal of Cancer 134:11, pages 2726-2734.
Crossref
Crossref
William R. Wilson, Kevin O. Hicks, Jingli Wang & Frederik B. Pruijn. 2014. Hypoxia and Cancer. Hypoxia and Cancer
283
328
.
Michael P. Hay, Kevin O. Hicks & Jingli Wang. 2014. Tumor Microenvironment and Cellular Stress. Tumor Microenvironment and Cellular Stress
111
145
.
Sara Strese, Mårten Fryknäs, Rolf Larsson & Joachim Gullbo. (2013) Effects of hypoxia on human cancer cell line chemosensitivity. BMC Cancer 13:1.
Crossref
Crossref
Hua Fang & Yves A. DeClerck. (2013) Targeting the Tumor Microenvironment: From Understanding Pathways to Effective Clinical Trials. Cancer Research 73:16, pages 4965-4977.
Crossref
Crossref
Juliana Benito, Zhihong Zeng, Marina KonoplevaWilliam R Wilson. (2013) Targeting hypoxia in the leukemia microenvironment. International Journal of Hematologic Oncology 2:4, pages 279-288.
Crossref
Crossref
L.A. Lievense, K. Bezemer, J.G.J.V. Aerts & J.P.J.J. Hegmans. (2013) Tumor-associated macrophages in thoracic malignancies. Lung Cancer 80:3, pages 256-262.
Crossref
Crossref
David S. Terman, Benjamin L. Viglianti, Rahima Zennadi, Diane Fels, Richard J. Boruta, Hong Yuan, Mathew R. Dreher, Gerald Grant, Zahid N. Rabbani, Ejung Moon, Lan Lan, Joseph Eble, Yiting Cao, Brian Sorg, Kathleen Ashcraft, Greg Palmer, Marilyn J. Telen & Mark W. Dewhirst. (2013) Sickle Erythrocytes Target Cytotoxics to Hypoxic Tumor Microvessels and Potentiate a Tumoricidal Response. PLoS ONE 8:1, pages e52543.
Crossref
Crossref
Lei Wang, Wenming Liu, Yaolei Wang, Jian-chun Wang, Qin Tu, Rui Liu & Jinyi Wang. (2013) Construction of oxygen and chemical concentration gradients in a single microfluidic device for studying tumor cell?drug interactions in a dynamic hypoxia microenvironment. Lab Chip 13:4, pages 695-705.
Crossref
Crossref
M. Busk, L. S. Mortensen, M. Nordsmark, J. Overgaard, S. Jakobsen, K. V. Hansen, J. Theil, J. F. Kallehauge, F. P. D’Andrea, T. Steiniche & M. R. Horsman. (2012) PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice. European Journal of Nuclear Medicine and Molecular Imaging 40:2, pages 186-197.
Crossref
Crossref
Yasuaki Harasaki & Allen Waziri. (2012) Potential Usefulness of Radiosensitizers in Glioblastoma. Neurosurgery Clinics of North America 23:3, pages 429-437.
Crossref
Crossref
Lin Wu, Jinhui Wu, Yuanyuan Zhou, Xiaolei Tang, Yanan Du & Yiqiao Hu. (2012) Enhanced antitumor efficacy of cisplatin by tirapazamine?transferrin conjugate. International Journal of Pharmaceutics 431:1-2, pages 190-196.
Crossref
Crossref
Shoucheng Ning, Mark Bednarski, Bryan Oronsky, Jan Scicinski, Gordon Saul & Susan J. Knox. (2012) Dinitroazetidines Are a Novel Class of Anticancer Agents and Hypoxia-Activated Radiation Sensitizers Developed from Highly Energetic Materials. Cancer Research 72:10, pages 2600-2608.
Crossref
Crossref
Jingli Wang, Annika Foehrenbacher, Jiechuang Su, Rita Patel, Michael P. Hay, Kevin O. Hicks & William R. Wilson. (2012) The 2-Nitroimidazole EF5 Is a Biomarker for Oxidoreductases That Activate the Bioreductive Prodrug CEN-209 under Hypoxia. Clinical Cancer Research 18:6, pages 1684-1695.
Crossref
Crossref
M Sund. (2012)
Effects of tirapazamine on experimental colorectal liver metastases after radiofrequency ablation (
Br J Surg
2012; 99: 567–575)
. British Journal of Surgery 99:4, pages 576-576.
Crossref
Crossref
Fanying Meng, James W. Evans, Deepthi Bhupathi, Monica Banica, Leslie Lan, Gustavo Lorente, Jian-Xin Duan, Xiaohong Cai, Alexandra M. Mowday, Christopher P. Guise, Andrej Maroz, Robert F. Anderson, Adam V. Patterson, Gregory C. Stachelek, Peter M. Glazer, Mark D. Matteucci & Charles P. Hart. (2012) Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302. Molecular Cancer Therapeutics 11:3, pages 740-751.
Crossref
Crossref
Justyna Sliwinska, Jaroslaw Dudka, Agnieszka Korga, Franciszek Burdan, Wlodzimierz Matysiak, Barbara Jodlowska-Jedrych, Slawomir Mandziuk & Katarzyna Dawidek-Pietryka. (2012)
Tirapazamine-Doxorubicin Interaction Referring to Heart Oxidative Stress and Ca
2+
Balance Protein Levels
. Oxidative Medicine and Cellular Longevity 2012, pages 1-9.
Crossref
Crossref
Kevin L Bennewith & Shoukat Dedhar. (2011) Targeting hypoxic tumour cells to overcome metastasis. BMC Cancer 11:1.
Crossref
Crossref
Bryan T. Oronsky, Susan J. Knox & Jan Scicinski. (2011) Six Degrees of Separation: The Oxygen Effect in the Development of Radiosensitizers. Translational Oncology 4:4, pages 189-198.
Crossref
Crossref
Jeffrey M CraftDennis Hallahan. (2011) Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapy. Future Medicinal Chemistry 3:7, pages 835-843.
Crossref
Crossref
Emma Ito, Kenneth W Yip & Fei-Fei Liu. (2011) Uroporphyrinogen decarboxylase: optimizing radiotherapy for head and neck cancer. Future Oncology 7:5, pages 595-597.
Crossref
Crossref
Aizhi Zhu & Hyunsuk Shim. (2011) Current Molecular Imaging Positron Emitting Radiotracers in Oncology. Nuclear Medicine and Molecular Imaging 45:1, pages 1-14.
Crossref
Crossref
Ann H. Klopp & Patricia J. Eifel. (2010) Chemoradiotherapy for Cervical Cancer in 2010. Current Oncology Reports 13:1, pages 77-85.
Crossref
Crossref
Xin Lu & Yibin Kang. (2010) Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis. Clinical Cancer Research 16:24, pages 5928-5935.
Crossref
Crossref
Mona El-Khatib, Fady Geara, Makhluf J Haddadin & Hala Gali-Muhtasib. (2010) Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21. Radiation Oncology 5:1.
Crossref
Crossref
Lucas Donovan, Scott M. Welford, John Haaga, Joseph LaManna & Kingman P. Strohl. (2010) Hypoxia—implications for pharmaceutical developments. Sleep and Breathing 14:4, pages 291-298.
Crossref
Crossref
Robert C Goldman. (2010) Maximizing bactericidal activity with combinations of bioreduced drugs. Future Medicinal Chemistry 2:8, pages 1253-1271.
Crossref
Crossref
. (2010) Current World Literature. Current Opinion in Otolaryngology & Head & Neck Surgery 18:2, pages 134-145.
Crossref
Crossref
Michele Avanzo, Joseph Stancanello, Giovanni Franchin, Giovanna Sartor, Rajesh Jena, Annalisa Drigo, Andrea Dassie, Marco Gigante & Elvira Capra. (2010) Correlation of a hypoxia based tumor control model with observed local control rates in nasopharyngeal carcinoma treated with chemoradiotherapy. Medical Physics 37:4, pages 1533-1544.
Crossref
Crossref
William A Denny. (2010) Hypoxia-activated prodrugs in cancer therapy: progress to the clinic. Future Oncology 6:3, pages 419-428.
Crossref
Crossref
Xiao-Feng Li, Xiaorong Sun, Yuanyuan Ma, Makiko Suehiro, Mutian Zhang, James Russell, John L. Humm, C. Clifton Ling & Joseph A. O’Donoghue. (2009) Detection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside (131I-IAZGP) digital autoradiography. European Journal of Nuclear Medicine and Molecular Imaging 37:2, pages 339-348.
Crossref
Crossref